HR 1082 119th Congress
Shandra Eisenga Human Cell and Tissue Product Safety Act
To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.
Official Title as Introduced Congress.gov
Open official Congress.gov recordSource-linked procedural record
Bill journey
This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.
Congress.gov Recently refreshed
U.S. Senate XML Recently refreshed
-
Introduction Congress.gov
Introduced
Introduced in the House.
Open bill recordOfficial action Congress.gov
Referred to the House Committee on Energy and Commerce.
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordText version Congress.gov
Introduced in House
A dated text-version record is available.
Open text record -
Official action Congress.gov
Ordered to be Reported by Voice Vote.
Open bill recordOfficial action Congress.gov
Committee Consideration and Mark-up Session Held
Open bill record -
Official action Congress.gov
Placed on the Union Calendar, Calendar No. 127.
Open bill recordOfficial action Congress.gov
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Open bill recordOfficial action Congress.gov
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Open bill recordText version Congress.gov
Reported in House
A dated text-version record is available.
Open text record -
Text version Congress.gov
Engrossed in House
A dated text-version record is available.
Open text recordOfficial action Congress.gov · 3:39 pm UTC
Mr. Bilirakis moved to suspend the rules and pass the bill.
Open bill recordOfficial action Congress.gov · 3:39 pm UTC
Considered under suspension of the rules. (consideration: CR H2860-2862)
Open bill recordOfficial action Congress.gov · 3:39 pm UTC
DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
Open bill recordOfficial action Congress.gov · 3:51 pm UTC
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Open bill recordOfficial action Congress.gov · 3:51 pm UTC
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Open bill recordOfficial action Congress.gov · 3:51 pm UTC
Motion to reconsider laid on the table Agreed to without objection.
Open bill record -
Official action Congress.gov
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Open bill recordText version Congress.gov
Referred in Senate
A dated text-version record is available.
Open text record
View the complete bill journey as an accessible table
| Date and time | Record | Official detail | Source |
|---|---|---|---|
| IntroductionIntroduced | Introduced in the House. | Congress.gov | |
| Official actionReferred to the House Committee on Energy and Commerce. | No additional detail supplied.IntroReferral · House floor actions · Code H11100 | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code Intro-H | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code 1000 | Congress.gov | |
| Text versionIntroduced in House | A dated text-version record is available. | Congress.gov | |
| Official actionOrdered to be Reported by Voice Vote. | No additional detail supplied.Committee · House committee actions · Code H19000 | Congress.gov | |
| Official actionCommittee Consideration and Mark-up Session Held | No additional detail supplied.Committee · House committee actions · Code H15001 | Congress.gov | |
| Official actionPlaced on the Union Calendar, Calendar No. 127. | No additional detail supplied.Calendars · House floor actions · Code H12410 | Congress.gov | |
| Official actionReported by the Committee on Energy and Commerce. H. Rept. 119-160. | No additional detail supplied.Committee · House floor actions · Code H12200 | Congress.gov | |
| Official actionReported by the Committee on Energy and Commerce. H. Rept. 119-160. | No additional detail supplied.Committee · Library of Congress · Code 5000 | Congress.gov | |
| Text versionReported in House | A dated text-version record is available. | Congress.gov | |
| Text versionEngrossed in House | A dated text-version record is available. | Congress.gov | |
| Official actionMr. Bilirakis moved to suspend the rules and pass the bill. | No additional detail supplied.Floor · House floor actions · Code H30300 | Congress.gov | |
| Official actionConsidered under suspension of the rules. (consideration: CR H2860-2862) | No additional detail supplied.Floor · House floor actions · Code H30000 | Congress.gov | |
| Official actionDEBATE - The House proceeded with forty minutes of debate on H.R. 1082. | No additional detail supplied.Floor · House floor actions · Code H8D000 | Congress.gov | |
| Official actionOn motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861) | No additional detail supplied.Floor · House floor actions · Code H37300 | Congress.gov | |
| Official actionPassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861) | No additional detail supplied.Floor · Library of Congress · Code 8000 | Congress.gov | |
| Official actionMotion to reconsider laid on the table Agreed to without objection. | No additional detail supplied.Floor · House floor actions · Code H38310 | Congress.gov | |
| Official actionReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | No additional detail supplied.IntroReferral · Senate | Congress.gov | |
| Text versionReferred in Senate | A dated text-version record is available. | Congress.gov |
House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.
Congressional Research Service
CRS summary
Shandra Eisenga Human Cell and Tissue Product Safety ActThis bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. (Human cell and tissue products are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.)Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor eligibility and current good tissue practice for manufacturing and distributing human cell and tissue products.Also, the bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion on the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and report to Congress with recommendations. The bill also requires the FDA to support the development of educational materials for health care professionals regarding organ, tissue, and eye donations and related topics.Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group (a working group within the FDA) and best practices for obtaining a recommendation from them about human cell and tissue products. Also, annually for three years, the FDA must publish on its website information on inquiries submitted to the Tissue Reference Group and FDA registrations and inspections regarding human cell and tissue manufacturers.
Official documents
Text versions
- Referred in SenateJun 24, 2025
- Engrossed in HouseJun 23, 2025
- Reported in HouseJun 12, 2025
- Introduced in HouseFeb 6, 2025